Regentis Biomaterials income statement data for the quarter ended Dec 2025. This income statement covers 2 quarters of results from Dec 2024 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2024 | Dec2025 |
|---|---|---|
| Additional items | ||
| Shares Outstanding | 2.77M | 0.57M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 2.77M | 0.57M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 2.77M | 0.57M |